Weekly Rounds with Infection Control Today: Omicron’s Symptoms, Biopreparedness, Electrostatic Cleaners
Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending December 10.
Here are 5 highlights from ICT®’s wide-ranging coverage of the infection prevention and control world. Everything from interviews with known opinion leaders, to the news that infection preventionists and other health care professionals can use on their jobs.
Winnie the Flu? Omicron Symptoms Mild So Far
Initial clinical data out of South Africa suggest that patients with the Omicron variant of COVID-19 don't have severe illness.
Add Biopreparedness to IP Checklist
Now is the time for infection preventionists to harness the current attention to biopreparedness and use the momentum to build the foundations for strong local programs that can be sustained through future waves of competing priorities.
Going Deep: Cleaning Potential of Electrostatic Sprayers
The electrostatic sprayer method kills nearly 100% of pathogens. It also kills the COVID-19 virus. But is that overkill?
Viewpoint: What Doesn’t Kill You Mutates and Tries Again
The looming surge from the Omicron variant may well have a lower case-fatality-rate but its high infectivity will further strain our health care system and fill our hospitals.
Prior COVID Infection Less Likely to Stop Omicron, Says Study
Exactly how the new variant of COVID-19 fares against vaccinated people continues to be studied.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
